Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 74
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharm Pharmacol ; 55(6): 847-53, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12841947

RESUMO

Smoke Shield is a proprietory formulation containing extract of turmeric (Curcuma longa), obtained by supercritical carbon dioxide gas extraction and post-supercritical hydroethanolic extraction, together with extracts of green tea and other spices whose presence synergistically increases the activity of turmeric. This study evaluates the antioxidant potentials of Smoke Shield in-vitro and in experimental animals, as well as in human models. Smoke Shield was found to scavenge superoxide radicals generated by photoreduction of riboflavin (50% inhibitory concentration = 91 microg mL(-1)) and hydroxyl radicals generated by Fenton reaction (50% inhibitory concentration = 95 microg mL(-1)) and reduced lipid peroxidation. Administration of Smoke Shield to mice was found to elevate antioxidant enzymes such as catalase and superoxide dismutase in blood as well as in liver and kidney. Glutathione-S-transferase activity was found to be significantly elevated in liver and kidney of animals treated with Smoke Shield. Glutathione levels were also significantly elevated in blood. Glutathione reductase was significantly elevated in kidney. Administration of Smoke Shield decreased the lipid peroxidation in serum, liver and kidney, as well as reduced the levels of conjugated dienes and hydroperoxides. Administration of Smoke Shield to smokers was found to increase the superoxide dismutase and glutathione in blood and decrease glutathione peroxidase. Smoke Shield inhibited phase I enzymes as represented by aniline-hydroxylase and aminopyrenedemethylase in-vitro. These results indicate that Smoke Shield has potent antioxidant activity, could inhibit phase I enzymes and increase detoxifying enzymes, which makes it an effective chemoprotective herbal formulation.


Assuntos
Antioxidantes/farmacologia , Inibidores Enzimáticos/farmacologia , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Extratos Vegetais/farmacologia , Aminopirina N-Desmetilase/antagonistas & inibidores , Anilina Hidroxilase/antagonistas & inibidores , Animais , Humanos , Rim/enzimologia , Fígado/enzimologia , Camundongos , Ratos , Fumar
2.
J Ethnopharmacol ; 81(1): 17-22, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12020923

RESUMO

Aqueous extract of Phyllanthus amarus (P. amarus) treatment exhibited potent anticarcinogenic activity against 20-methylcholanthrene (20-MC) induced sarcoma development and increased the survival of tumour harboring mice. The extract administration (p.o) was also found to prolong the life span of Dalton's Lymphoma Ascites (DLA) and Ehrlich Ascites Carcinoma (EAC) bearing mice and reduced the volume of transplanted solid tumours. The extract inhibited aniline hydroxylase, a P-450 enzyme. The concentration required for 50% inhibition (IC(50)) was found to be 540 microg/ml. The extract was found to inhibit DNA topoisomerase II of Saccharomyces cerevisiae mutant cell cultures and inhibited cell cycle regulatory enzyme cdc25 tyrosine phosphatase (IC(50-25) microg/ml). Antitumour and anticancer activity of P. amarus may be related with the inhibition of metabolic activation of carcinogen as well as the inhibition of cell cycle regulators and DNA repair.


Assuntos
Anticarcinógenos/farmacologia , Antineoplásicos Fitogênicos/farmacologia , Phyllanthus , Extratos Vegetais/farmacologia , Anilina Hidroxilase/antagonistas & inibidores , Anilina Hidroxilase/metabolismo , Animais , Anticarcinógenos/administração & dosagem , Antineoplásicos Fitogênicos/administração & dosagem , Proteína Quinase CDC2/antagonistas & inibidores , Proteína Quinase CDC2/metabolismo , Carcinoma de Ehrlich/tratamento farmacológico , Carcinoma de Ehrlich/patologia , Ciclo Celular/efeitos dos fármacos , Reparo do DNA/efeitos dos fármacos , DNA Topoisomerases/metabolismo , Relação Dose-Resposta a Droga , Feminino , Concentração Inibidora 50 , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Transplante de Neoplasias , Fitoterapia , Extratos Vegetais/administração & dosagem , Saccharomyces cerevisiae/citologia , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/enzimologia , Saccharomyces cerevisiae/genética , Sarcoma/induzido quimicamente , Sarcoma/tratamento farmacológico , Sarcoma/patologia , Taxa de Sobrevida , Inibidores da Topoisomerase , Células Tumorais Cultivadas , Fosfatases cdc25/antagonistas & inibidores , Fosfatases cdc25/metabolismo
3.
J Ethnopharmacol ; 71(1-2): 261-6, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10904172

RESUMO

Anti-tumour and anti-carcinogenic activity of Picrorrhiza kurroa extract were studied in mice. Administration of 20-methylcholanthrene (20 MC) produced 100% induction of sarcoma in control mice, whereas the tumour incidence and tumour related deaths were significantly inhibited by the oral administration of P. kurroa extract 150 and 750 mg/kg body weight, respectively. The extract was also found to reduce the volume of transplanted solid tumours induced by Dalton's lymphoma ascites (DLA) tumour cell lines and increased the life span of ascites tumour bearing mice. P. kurroa extract inhibited yeast topoisomerase I and II enzyme activity when tested on Saccharomyces cerevisiae mutant cell cultures. The extract did not inhibit the enzyme involved in the activation of carcinogen and the cell cycle regulatory enzyme cdc2 kinase.


Assuntos
Anticarcinógenos/farmacologia , Antineoplásicos Fitogênicos/farmacologia , Plantas Medicinais/química , Anilina Hidroxilase/antagonistas & inibidores , Animais , Anticarcinógenos/isolamento & purificação , Antineoplásicos Fitogênicos/isolamento & purificação , Proteína Quinase CDC2/antagonistas & inibidores , Carcinógenos/toxicidade , Inibidores Enzimáticos/isolamento & purificação , Inibidores Enzimáticos/farmacologia , Índia , Masculino , Metilcolantreno/toxicidade , Camundongos , Transplante de Neoplasias , Extratos Vegetais/farmacologia , Sarcoma Experimental/tratamento farmacológico , Análise de Sobrevida , Inibidores da Topoisomerase I , Inibidores da Topoisomerase II
4.
Drug Metab Dispos ; 28(4): 409-17, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10725309

RESUMO

Some macrolide antibiotics cause clinical drug interactions, resulting in altered metabolism of concomitantly administered drugs, via the formation of a metabolic intermediate (MI) complex with cytochrome P450 (CYP), or competitive inhibition of CYP. In this study, the possibility of MI complex formation by miocamycin (MOM) was assessed first. CYP contents and activities in rat liver microsomes were not affected and there were no detectable MI complexes after administration of MOM for either 3 or 10 days to rats. Furthermore, MOM did not form MI complexes in vitro even with microsomes from humans or dexamethasone-pretreated rats. Second, in vitro studies were conducted to identify the human CYP isoforms involved in four 14-hydroxylation reactions in the MOM metabolic pathway. The results showed that it was most likely CYP3A4 involved in the hydroxylations: 1) each hydroxylation in human liver microsomes from 10 different donors strongly correlated with testosterone 6 beta-hydroxylation; 2) each hydroxylation was essentially inhibited by ketoconazole and troleandomycin; 3) only cDNA-expressed CYP3A4 and CYP3A5 catalyzed the hydroxylations, and the activities of CYP3A5 were below 5% of those of CYP3A4; and 4) the apparent K(M) values obtained with native human liver microsomes were comparable with those obtained with cDNA-expressed CYP3A4. In conclusion, MOM is not an inhibitor of CYP via the formation of an MI complex. Moreover, CYP3A4 is mainly responsible for catalyzing the hydroxylation of MOM metabolites. Because CYP3A4 is the most abundant form of CYP in the liver and intestine, this isoform probably accounts for the majority of drug-MOM interactions observed in clinical practice.


Assuntos
Antibacterianos/farmacocinética , Sistema Enzimático do Citocromo P-450/metabolismo , Miocamicina/farmacocinética , Anilina Hidroxilase/antagonistas & inibidores , Anilina Hidroxilase/metabolismo , Animais , Cromatografia Líquida de Alta Pressão , Citocromo P-450 CYP1A1/antagonistas & inibidores , Citocromo P-450 CYP1A1/metabolismo , Inibidores das Enzimas do Citocromo P-450 , Inibidores Enzimáticos/farmacologia , Humanos , Hidroxilação , Técnicas In Vitro , Isoenzimas/antagonistas & inibidores , Isoenzimas/metabolismo , Cinética , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Microssomos Hepáticos/metabolismo , Ratos , Ratos Sprague-Dawley , Análise de Regressão , Testosterona/metabolismo
5.
Toxicol Lett ; 114(1-3): 39-45, 2000 Apr 03.
Artigo em Inglês | MEDLINE | ID: mdl-10713467

RESUMO

Influenza virus infection was associated with development of oxidative stress in liver of mice, viz. increase in amount of lipid peroxidation products, decrease in cytochrome P-450 and NADP. H-cytochrome c-reductase activity, and inhibition of liver monooxygenases (aniline hydroxylase, ethylmorphine-N-demethylase, amidopyrine-N-demethylase and analgin-N-demethylase). These effects were most pronounced on the 7th day after virus inoculation as compared to the 5th one. Supplementation of mice with vitamin E before virus inoculation leads to liver protection against oxidative stress and toxicosis. A marked decrease of lipid peroxidation products and an increase of cytochrome P-450 and activities of monooxygenases was established. The stabilizing effect of vitamin E was dose-dependent and was most pronounced on the 5th day after virus inoculation as compared to the 7th one.


Assuntos
Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/enzimologia , Infecções por Orthomyxoviridae/enzimologia , Vitamina E/farmacologia , Aminopirina N-Desmetilase/antagonistas & inibidores , Aminopirina N-Desmetilase/metabolismo , Anilina Hidroxilase/antagonistas & inibidores , Anilina Hidroxilase/metabolismo , Animais , Inibidores das Enzimas do Citocromo P-450 , Sistema Enzimático do Citocromo P-450/metabolismo , Dipirona/metabolismo , Relação Dose-Resposta a Droga , Etilmorfina-N-Demetilasa/antagonistas & inibidores , Etilmorfina-N-Demetilasa/metabolismo , Vírus da Influenza A/metabolismo , Fígado/virologia , Masculino , Camundongos , NADPH-Ferri-Hemoproteína Redutase/metabolismo , Infecções por Orthomyxoviridae/tratamento farmacológico , Estresse Oxidativo/efeitos dos fármacos , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
6.
Mutat Res ; 402(1-2): 247-58, 1998 Jun 18.
Artigo em Inglês | MEDLINE | ID: mdl-9675301

RESUMO

Fifteen kinds of commonly consumed Thai vegetables were sequentially extracted with hexane, chloroform and methanol, and then tested for antimutagenic activities against direct-acting (AF-2 and NaN3) and indirect-acting (AFB1 and B(a)P) mutagens using Ames' Salmonella mutagenicity test with Salmonella typhimurium TA100 as tester strain. It was found that only the methanol extract of neem leaves contain weak antimutagen inhibiting the mutagenicities of both direct-acting mutagens. Interestingly, all vegetables studied were found to contain chemical compounds, mainly nonpolar ones, capable of inhibiting the mutagenicity of AFB1, while only some vegetables contain chemical compounds capable of inhibiting the mutagenicity of B(a)P, which is also an indirect-acting mutagen. Studies on anticarcinogenic potentials demonstrated that Thai bitter gourd fruits, but not sweet basil leaves, at the concentration of 6.25% and 12.5% in the diet, partially inhibited DMBA-induced mammary gland carcinogenesis in female Sprague-Dawley rats when fed to the animals 2 weeks prior to DMBA. Results in the present study therefore demonstrated that most Thai vegetables contain antimutagens inhibiting the mutagenicity of some indirect-acting mutagen, particularly AFB1. The mechanism of their antimutagenicity may probably be the inhibition of the activity of metabolic-activating enzymes in rat liver homogenates. Very interestingly, our results clearly reveal that Thai bitter gourd fruits, which possess Phase II enzymes inducing property, as well as the ability to reduce Phase I enzyme activities in rat liver, contain some anticarcinogens or chemopreventive agents. However, sweet basil leaves that possess both Phase I and Phase II enzyme-inducing properties may not contain any anticarcinogen, at least against DMBA-induced mammary gland carcinogenesis.


Assuntos
Anticarcinógenos/farmacologia , Antimutagênicos/farmacologia , Verduras/química , Aminopirina N-Desmetilase/antagonistas & inibidores , Anilina Hidroxilase/antagonistas & inibidores , Animais , Anticarcinógenos/análise , Antimutagênicos/análise , Feminino , Fígado/efeitos dos fármacos , Fígado/enzimologia , Neoplasias Mamárias Experimentais/prevenção & controle , Testes de Mutagenicidade , Ratos , Ratos Sprague-Dawley , Salmonella typhimurium/genética , Tailândia
7.
Vet Hum Toxicol ; 39(5): 272-5, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9311082

RESUMO

Hepatic bovine microsomes were incubated with Zineb concentrations ranging from 2.5 mM to 2.5 microM. Only the higher concentrations of the fungicide (2.5 and 0.25 mM) elicited a sharp decline in cytochrome P450, cytochrome b5 and total sulphydryl groups content as well as in the activities of NADPH cytochrome c reductase, aminopyrine N-demethylase and aniline 4-hydroxylase. The loss of cytochrome P450 was matched by a concomitant increase in the amount of cytochrome P420, which represents a catalytically inactive form of cytochrome P450. The same concentrations of the fungicide, either alone or in the presence of NADPH 1 mM, failed to increase the amount of thiobarbituric reactive substances with respect to control incubations, thereby excluding the possibility of lipid peroxidation as a contributing factor in the loss of cytochrome P450 and in the inhibition of cytochrome P450-mediated metabolism. It is concluded that Zineb can depress monooxygenase activity in bovine hepatic microsomes mainly through the denaturation of cytochrome P450 and the impaired transfer of reducing equivalents to the complex cytochrome P450-substrate. These mechanisms might also account for the inhibition in lipid peroxidation brought about by the fungicide.


Assuntos
Fungicidas Industriais/toxicidade , Peroxidação de Lipídeos/efeitos dos fármacos , Microssomos Hepáticos/efeitos dos fármacos , Zineb/toxicidade , Aminopirina N-Desmetilase/antagonistas & inibidores , Anilina Hidroxilase/antagonistas & inibidores , Animais , Bovinos , Inibidores das Enzimas do Citocromo P-450 , Citocromos/metabolismo , Citocromos b5/antagonistas & inibidores , Microssomos Hepáticos/enzimologia , NADPH-Ferri-Hemoproteína Redutase/antagonistas & inibidores , Compostos de Sulfidrila/análise
8.
Int J Biochem Cell Biol ; 29(6): 921-8, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9304807

RESUMO

The effects of an immunosuppressive agent, tacrolimus (FK-506), on the activities of cytochrome P-450-linked monooxygenase systems with respect to three cytochrome P-450 isozymes in rat liver microsomes were investigated. FK-506 non-competitively inhibited the aniline p-hydroxylase, p-nitroanisole O-demethylase and lidocaine N-deethylase activities of cytochrome P-450-linked monooxygenase systems, these activities being mainly catalyzed by cytochromes P-450 CYP2E1, CYP2C11 and CYP3A4, respectively, and the Ki values of the activities for FK-506 were determined to be 605, 491 and 97 microM, respectively. The inhibition of cytochrome P-450-linked monooxygenase systems by FK-506 seemed to involve the direct inhibition of cytochromes P-450 because the NADPH-cytochrome c reductase and NADPH-ferricyanide reductase activities of NADPH-cytochrome P-450 reductase were not affected by the presence of 1 mM FK-506 at all. A spectrophotometric study showed that a reverse type I spectral change was induced on the addition of FK-506 to rat liver microsomes, and the Ks value was apparently 125 microM. On the other hand, the EPR spectra of cytochromes P-450 in rat liver microsomes were not affected by 1 mM FK-506. These results suggest direct interaction between FK-506 and cytochrome P-450 apoproteins, except for the heme iron regions of cytochromes P-450, resulting in inhibition of the drug-metabolism activities catalyzed by cytochromes P-450.


Assuntos
Inibidores das Enzimas do Citocromo P-450 , Inibidores Enzimáticos/farmacologia , Imunossupressores/farmacologia , Microssomos Hepáticos/efeitos dos fármacos , Tacrolimo/farmacologia , Anilina Hidroxilase/antagonistas & inibidores , Animais , Sistema Enzimático do Citocromo P-450 , Cinética , Masculino , Microssomos Hepáticos/enzimologia , NADH NADPH Oxirredutases/efeitos dos fármacos , NADPH-Ferri-Hemoproteína Redutase/efeitos dos fármacos , Oxirredutases/antagonistas & inibidores , Oxirredutases O-Desmetilantes/antagonistas & inibidores , Ratos , Ratos Sprague-Dawley
9.
Eur J Pharmacol ; 293(3): 231-5, 1995 Oct 06.
Artigo em Inglês | MEDLINE | ID: mdl-8666040

RESUMO

We reported previously that 18 compounds varying in general anesthetic potency by up to 66 000-fold inhibited, at anesthetic concentrations, the metabolism of arachidonic acid and aminopyrine by cytochrome P450 monooxygenases in rat liver microsomes. Now, we report that P450-mediated para-hydroxylation of aniline is more sensitive to the anesthetics. The Ki values for enzyme inhibition for seven compounds were close to and for seven compounds 5-40 times less than their respective anesthetic potencies. Endogenous substrates with an aniline-like binding mode to P450 include histamine and related imidazoles. Acetone and each of the halogenated compounds, halothane, enflurane, and chloroform, stimulated aniline hydroxylase activity at concentrations well below and above their EC50 values. These potent actions on the universal P450 isoenzymes may contribute to pharmacological effects of the anesthetics associated with levels of drug well below concentrations that effect general anesthesia.


Assuntos
Anestésicos/farmacologia , Compostos de Anilina/metabolismo , Inibidores das Enzimas do Citocromo P-450 , Microssomos Hepáticos/metabolismo , Anilina Hidroxilase/antagonistas & inibidores , Anilina Hidroxilase/metabolismo , Animais , Relação Dose-Resposta a Droga , Hidroxilação/efeitos dos fármacos , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley
10.
Biochem Pharmacol ; 49(11): 1657-63, 1995 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-7786307

RESUMO

To evaluate how two inhibitors influence oxidative drug metabolism, this study investigated the inhibitory effects of mexiletine with cimetidine and mexiletine with lidocaine, both individually and in combination, on the oxidative metabolism of two probe substrates, aminopyrine and aniline in rat liver microsomes. Mexiletine was a competitive inhibitor of aminopyrine N-demethylation, whereas cimetidine was a mixed type of inhibitor (Ki = 2.00 +/- 0.04 and 0.20 +/- 0.02 mM, respectively). For aniline hydroxylation, mexiletine exhibited a mixed type of inhibition, whereas lidocaine was a noncompetitive inhibitor (Ki = 0.60 +/- 0.07 and 8.50 +/- 0.12 mM, respectively). The combined inhibition of either mexiletine with cimetidine or mexiletine with lidocaine on aminopyrine and aniline metabolism was close to the fully additive effects of the individual compounds when their individual concentrations were below a 2-fold Ki concentration, regardless of the apparent kinetic inhibition type. The combined inhibition was less than fully additive when the individual concentrations were twice the Ki or above. These results demonstrate that, when two inhibitors of oxidative drug metabolism are combined, both the Ki values and the concentrations of inhibitors play important roles in determining the extent of additive inhibition of enzyme activity.


Assuntos
Aminopirina N-Desmetilase/antagonistas & inibidores , Anilina Hidroxilase/antagonistas & inibidores , Cimetidina/farmacologia , Lidocaína/farmacologia , Mexiletina/farmacologia , Microssomos Hepáticos/metabolismo , Animais , Cinética , Masculino , Ratos , Ratos Sprague-Dawley
11.
J Neurochem ; 64(5): 2169-76, 1995 May.
Artigo em Inglês | MEDLINE | ID: mdl-7722502

RESUMO

A peripheral neuropathy characterized by a transient demyelinating/remyelinating sequence results when young rats are fed a tellurium-containing diet. The neuropathy occurs secondary to a systemic block in cholesterol synthesis. Squalene accumulation suggested the lesion was at the level of squalene expoxidase, a microsomal monooxygenase that uses NADPH cytochrome P450 reductase to receive its necessary reducing equivalents from NADPH. We have now demonstrated directly specificity for squalene epoxidase; our in vitro studies show that squalene epoxidase is inhibited 50% in the presence of 5 microM tellurite, the presumptive in vivo active metabolite. Under these conditions, the activities of other monooxygenases, aniline hydroxylase and benzo(a)pyrene hydroxylase, were inhibited less than 5%. We also present data suggesting that tellurite inhibits squalene epoxidation by interacting with highly susceptible -SH groups present on this monooxygenase. In vivo studies of specificity were based on the compensatory response to feeding of tellurium. Following tellurium intoxication, there was up-regulation of squalene epoxidase activity both in liver (11-fold) and sciatic nerve (fivefold). This induction was a specific response, as demonstrated in liver by the lack of up-regulation following exposure to the nonspecific microsomal enzyme inducer, phenobarbital. As a control, we also measured the microsomal monooxygenase activities of aniline hydroxylase and benzo(a)pyrene hydroxylase. Although they were induced following phenobarbital exposure, activities of these monooxygenases were not affected following tellurium intoxication, providing further evidence of specificity of tellurium intoxication for squalene epoxidase.


Assuntos
Oxigenases/antagonistas & inibidores , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Telúrio/farmacologia , Telúrio/toxicidade , Anilina Hidroxilase/antagonistas & inibidores , Anilina Hidroxilase/metabolismo , Animais , Benzopireno Hidroxilase/antagonistas & inibidores , Benzopireno Hidroxilase/metabolismo , Fígado/enzimologia , NADPH-Ferri-Hemoproteína Redutase/antagonistas & inibidores , NADPH-Ferri-Hemoproteína Redutase/metabolismo , Oxigenases/metabolismo , Doenças do Sistema Nervoso Periférico/enzimologia , Ratos , Nervo Isquiático/enzimologia , Esqualeno Mono-Oxigenase , Compostos de Sulfidrila/química
12.
J Pharm Pharmacol ; 46(5): 360-5, 1994 May.
Artigo em Inglês | MEDLINE | ID: mdl-8083807

RESUMO

Interactions between some novel and potent monoamine oxidase inhibitors (MAOIs), acetylenic analogues of tryptamine, and rat liver microsomal cytochrome P450 (P450) as evidenced by visible spectra analysis were analysed. Compounds with a secondary aliphatic amine moiety throughout induced type II difference spectra and exhibited the highest affinity for P450, whereas tertiary amines induced type I spectral changes and showed diminished affinity. P450 dependent aniline hydroxylase activity was inhibited by all compounds in an irreversible time-dependent manner. Only tertiary aliphatic amines constituted the substrate for P450-dependent N-demethylase activity, with comparable kinetic parameters. The N-demethylated metabolites were identified by thin-layer chromatography and mass-spectrometric analyses. These findings describe the role of P450-dependent microsomal mono-oxygenase systems in the metabolism of some MAOI acetylenic tryptamine derivatives and the possible hepatic contribution to adverse interactions between MAOIs, endobiotics and sympathomimetic compounds.


Assuntos
Acetileno/metabolismo , Sistema Enzimático do Citocromo P-450/metabolismo , Microssomos Hepáticos/enzimologia , Inibidores da Monoaminoxidase/metabolismo , Triptaminas/metabolismo , Anilina Hidroxilase/antagonistas & inibidores , Animais , Cromatografia em Camada Fina , Técnicas In Vitro , Masculino , Espectrometria de Massas , Estrutura Molecular , Ratos , Ratos Sprague-Dawley , Análise Espectral
13.
Environ Health Perspect ; 101 Suppl 3: 247-52, 1993 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8143625

RESUMO

The edible part of fresh Chinese radish was chopped into small pieces, lyophilized, and then extracted sequentially with hexane, chloroform, and methanol. The solvent in each fraction was removed by evaporation under reduced pressure at 50-55 degrees C, and the residue was dissolved in dimethylsufoxide just before being tested for antimutagenicity as well as mutagenicity using the Salmonella/mammalian microsome mutagenicity test. We found that none of the three fractions exhibited any mutagenicity toward S. typhimurium strains TA98 and TA100 when tested either in the presence or absence of S-9 mix. Interestingly, however, hexane and chloroform extracts could strongly inhibit the mutagenicities of both direct mutagens (e.g., 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide and sodium azide) and indirect mutagens (e.g., aflatoxin B1). In contrast, however, these two fractions did not inhibit the mutagenicity of benzo[a]pyrene, which is also an indirect mutagen. Both hexane and chloroform extracts could also markedly inhibit the activities of rat liver aniline hydroxylase and aminopyrine demethylase. The methanol fraction could inhibit neither the mutagenicities of direct or indirect mutagens tested nor the activities of those two rat liver enzymes. Results of the present study demonstrate that Chinese radish may not contain any mutagenic compound but does contain some nonpolar compounds with antimutagenic activity toward both direct and indirect mutagens. In addition, the antimutagenic activity toward aflatoxin B1 may be partly due to the inhibition of enzymes necessary for activation of this mutagen.


Assuntos
Antimutagênicos/farmacologia , Mutagênicos/efeitos adversos , Verduras/química , Aminopirina N-Desmetilase/antagonistas & inibidores , Anilina Hidroxilase/antagonistas & inibidores , Animais , Fígado/efeitos dos fármacos , Fígado/enzimologia , Testes de Mutagenicidade , Extratos Vegetais/farmacologia , Ratos , Salmonella typhimurium/genética
14.
Biol Trace Elem Res ; 38(2): 129-37, 1993 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7508249

RESUMO

When Cd (3.58 mg CdCl2.H2O/kg, ip) was administered to male guinea pigs 72 h prior to sacrifice, the metal significantly inhibited the aniline 4-hydroxylase (AH) (16%), ethylmorphone N-demethylase (EMND) (26%), and aminopyrine N-demethylase (AMND) (18%) activities and cytochrome P-450 (12%) and cytochrome b5 (10%) levels. Cd did not alter the hepatic microsomal heme level. Cd, however, significantly increased the hepatic microsomal p-nitroanisole O-demethylase (p-NAOD) (53%) activity. When Ni (59.5 mg NiCl2 x 6H2O/kg, sc) was administered to the guinea pigs 16 h prior to sacrifice, the metal significantly depressed AH (49%), p-NAOD (66%), EMND (47%), and AMND (37%) activities, and cytochrome P-450 (15%), cytochrome b5 (24%), and microsomal heme (28%) levels. For the combined treatment, animals received the single dose of Ni 56 h after the single dose of Cd and then were killed 16 h later. In these animals, significant inhibitions were noted in AH (51%), EMND (47%), and AMND (30%) activities, and cytochrome P-450 (15%), cytochrome b5 (26%), and microsomal heme (30%) compared to those of controls. In the case of p-NAOD activity, the influence was in favor of Ni, i.e., the inhibition was about 61% by the combined treatment.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Cádmio/toxicidade , Fígado/enzimologia , Níquel/toxicidade , Oxirredutases/antagonistas & inibidores , Aminopirina N-Desmetilase/antagonistas & inibidores , Anilina Hidroxilase/antagonistas & inibidores , Animais , Inibidores das Enzimas do Citocromo P-450 , Cobaias , Fígado/efeitos dos fármacos , Masculino , Nitroanisol O-Desmetilase/antagonistas & inibidores
15.
Biochem Pharmacol ; 44(10): 2021-7, 1992 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-1333203

RESUMO

Theophylline (Th) under in vitro conditions stimulated the activities of rat liver microsomal aniline hydroxylase, N-demethylase and O-demethylase, while delta-9-tetrahydrocannabinol (delta-9-THC) inhibited the activities of these hepatic microsomal drug metabolizing enzymes under similar conditions. delta-9-THC-induced inhibition of hepatic microsomal drug metabolizing enzymes was significantly reduced in the presence of Th. Analysis of Lineweaver-Burk plots showed that Th-induced stimulation of hepatic microsomal drug metabolizing enzymes occurs due to an increase in substrate affinity (1/Km) and of Vmax. delta-9-THC-induced inhibition of N-demethylase and O-demethylase is probably due to competition of the drug with the substrates for a common intermediate in the microsomal electron transport chain. Non-competitive and mixed-type inhibition caused by delta-9-THC on aniline hydroxylation appears to be associated with a non-specific action of delta-9-THC. Blocking of delta-9-THC-induced inhibition or reduction of Th-induced stimulation of hepatic drug metabolizing enzymes with Th or delta-9-THC was due to an increase or decrease in either Vmax, substrate affinity (1/Km) or both with respect to the corresponding Km and Vmax observed with delta-9-THC or Th alone.


Assuntos
Dronabinol/farmacologia , Microssomos Hepáticos/efeitos dos fármacos , Teofilina/farmacologia , Anilina Hidroxilase/antagonistas & inibidores , Animais , Interações Medicamentosas , Ativação Enzimática/efeitos dos fármacos , Cinética , Masculino , Microssomos Hepáticos/enzimologia , Oxirredutases N-Desmetilantes/antagonistas & inibidores , Oxirredutases O-Desmetilantes/antagonistas & inibidores , Ratos
16.
Toxicol Lett ; 55(3): 317-23, 1991 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1900643

RESUMO

Dimethyl sulfoxide (DMSO) at a single dose of 3 ml/kg body wt, administered i.p. to male rats, caused a significant increase in the hepatic microsomal aniline hydroxylase activity. However, the level of cytochrome P-450, the activities of NADPH-cytochrome c reductase, benzphetamine N-demethylase and aminopyrine N-demethylase were unchanged at 24 h post-treatment. DMSO interacted with control rat liver microsomes in vitro and produced a type II spectral change (peak at 420 nm and trough at 392 nm). On the other hand, liver microsomes from DMSO-treated rats gave qualitatively similar spectra, but with a higher magnitude of binding. Liver microsomes from DMSO-treated rats showed a 3.4-fold increase in Vmax for aniline hydroxylase, while Km was found to be the same when compared with control rat liver microsomes. In vitro addition of 6 mM DMSO to microsomal incubations from control and DMSO-treated rats caused a 9-fold and a 25-fold increase in Km, respectively, while Vmax values for aniline hydroxylase were unchanged. When DMSO (6 mM) was incubated with rat liver microsomes in the presence of NADPH, there was formation of formaldehyde. The results suggest an interaction of DMSO with microsomal cytochrome P-450.


Assuntos
Anilina Hidroxilase/metabolismo , Dimetil Sulfóxido/toxicidade , Microssomos Hepáticos/efeitos dos fármacos , Aminopirina N-Desmetilase/antagonistas & inibidores , Aminopirina N-Desmetilase/metabolismo , Anilina Hidroxilase/antagonistas & inibidores , Animais , Inibidores das Enzimas do Citocromo P-450 , Sistema Enzimático do Citocromo P-450/metabolismo , Técnicas In Vitro , Masculino , Microssomos Hepáticos/enzimologia , NADPH-Ferri-Hemoproteína Redutase/antagonistas & inibidores , NADPH-Ferri-Hemoproteína Redutase/metabolismo , Oxirredutases N-Desmetilantes/antagonistas & inibidores , Oxirredutases N-Desmetilantes/metabolismo , Ratos , Ratos Endogâmicos
17.
Free Radic Res Commun ; 14(5-6): 419-31, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1663909

RESUMO

(5-Nitro-2-furfurylidene)amino compounds bearing triazol-4-yl, benzimidazol-1-yl, pyrazol-1-yl, triazin-4-yl or related groups (a) stimulated superoxide anion radical generated by rat liver microsomes in the presence of NADPH and oxygen; (b) inhibited the NADPH-dependent, iron-catalyzed microsomal lipid peroxidation; (c) prevented the NADPH-dependent destruction of cytochrome P-450; (d) inhibited the NADPH-dependent microsomal aniline 4-hydroxylase activity; (e) failed to inhibit either the cumenyl hydroperoxide-dependent lipid peroxidation or the aniline-4-hydroxylase activity, except for the benzimidazol-1-yl and the substituted triazol-4-yl derivatives, which produced minor inhibitions. Reducing equivalents enhanced the benzimidazol-1-yl derivative inhibition of the cumenyl hydroperoxide-induced lipid peroxidation. The ESR spectrum of the benzimidazol-1-yl derivative, reduced anaerobically by NADPH-supplemented microsomes, showed characteristic spin couplings. Compounds bearing unsaturated nitrogen heterocycles were always more active than those bearing other groups, such as nifurtimox or nitrofurazone. The energy level of the lowest unoccupied molecular orbital was in fair agreement with the capability of nitrofurans for redox-cycling and related actions. It is concluded that nitrofuran inhibition of microsomal lipid peroxidation and cytochrome P-450-catalyzed reactions was mostly due to diversion of reducing equivalents from NADPH to dioxygen. Trapping of free radicals involved in propagating lipid peroxidation might contribute to the overall effect of the benzimidazol-1-yl and substituted triazol-4-yl derivatives.


Assuntos
Inibidores das Enzimas do Citocromo P-450 , Peroxidação de Lipídeos/efeitos dos fármacos , Microssomos/efeitos dos fármacos , Nitrofuranos/farmacologia , Anilina Hidroxilase/antagonistas & inibidores , Animais , Espectroscopia de Ressonância de Spin Eletrônica , Ferro/metabolismo , Fígado , Masculino , Malondialdeído/análise , Microssomos/metabolismo , NADP/metabolismo , Nifurtimox/análogos & derivados , Nifurtimox/farmacologia , Oxirredução , Oxigênio/metabolismo , Ratos , Ratos Endogâmicos , Superóxidos/metabolismo
18.
Artigo em Inglês | MEDLINE | ID: mdl-1936056

RESUMO

The effects of cimetidine on drug metabolism were studied in male and female rat pups and compared to similar effects in adult rats. As in adult rats, cimetidine 50 mg/kg/day i.p. for 7 days in the 2nd, 3rd, 4th or 5th weeks of life resulted in prolonged pentobarbitone sleeping times (diminished pentobarbitone hydroxylase activities), particularly when administered during the 3rd week. These effects of cimetidine were reversible since they continued only up to 2 weeks in males and 4 weeks in females, but by the 6th week were no longer observed. Pretreatment with cimetidine 15, 25 and 50 mg/kg/day i.p. for 7 days, resulted in a dose-dependent inhibition of aminopyrine N-demethylase and aniline hydroxylase as well as a prolongation of pentobarbitone sleeping time in both pups and adults, aniline hydroxylase being the least affected. In general, female pups were more adversely affected than male pups and adults. The therapeutic and toxicological relevance of these results in man are discussed.


Assuntos
Aminopirina/metabolismo , Compostos de Anilina/metabolismo , Cimetidina/farmacologia , Aminopirina N-Desmetilase/antagonistas & inibidores , Anilina Hidroxilase/antagonistas & inibidores , Animais , Cimetidina/administração & dosagem , Interações Medicamentosas , Feminino , Masculino , Oxigenases de Função Mista/antagonistas & inibidores , Pentobarbital/metabolismo , Ratos , Ratos Endogâmicos
19.
Toxicol Appl Pharmacol ; 105(2): 333-9, 1990 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-2219123

RESUMO

In rat liver microsomes, 2-methyl-1,4-naphthoquinone (menadione) inhibits cytochrome P450 (cyt P450)-mediated aniline-p-hydroxylation and aminopyrine-N-demethylation with Ki values of 12 and 14.5 microM, respectively. The inhibitions of aniline-p-hydroxylation and aminopyrine-N-demethylation are mixed uncompetitive-noncompetitive and mixed competitive-noncompetitive, respectively. NADP antagonizes the inhibitory effect of menadione on aniline-p-hydroxylase activity but not that on aminopyrine-N-demethylase activity. Menadione does not give rise to any spectral change of cyt P450, but modifies the type I binding spectrum induced by aminopyrine. In contrast, menadione does not change the type II binding spectrum induced by aniline. These results indicate that menadione may inhibit aniline-p-hydroxylase activity by acting as a substrate for NADPH-cyt P450 reductase in the place of cyt P450 and inhibit aminopyrine-N-demethylase activity by impairing the binding of aminopyrine to cyt P450.


Assuntos
Aminopirina N-Desmetilase/antagonistas & inibidores , Anilina Hidroxilase/antagonistas & inibidores , Sistema Enzimático do Citocromo P-450/metabolismo , Microssomos Hepáticos/enzimologia , Vitamina K/farmacologia , Animais , Inibidores das Enzimas do Citocromo P-450 , Cinética , Masculino , Microssomos Hepáticos/efeitos dos fármacos , NADP/metabolismo , Oxirredução , Ratos , Ratos Endogâmicos , Espectrofotometria
20.
Vopr Med Khim ; 36(3): 52-4, 1990.
Artigo em Russo | MEDLINE | ID: mdl-2382429

RESUMO

Content and activity of cytochrome P-450, activity of main microsomal enzymes as well as content of glycogen, lactic and pyruvic acids were studied in liver tissue of rats within 24, 48 and 72 hrs after simulation of acute fecal peritonitis. Inhibition of the enzymatic activity of microsomal oxidative system correlated with hypoxia which developed in liver tissue within all the periods of acute fecal peritonitis studied. At the same time, catalytic activity of cytochrome P-450 was increased towards substrates of the I and II types. Endotoxemia and hypoxia of liver tissue, resulting in activation of phospholipases, appear to be mainly responsible for inhibition of microsomal enzymes activity in liver tissue under conditions of acute peritonitis.


Assuntos
Fezes , Microssomos Hepáticos/enzimologia , Peritonite/enzimologia , Doença Aguda , Aminopirina N-Desmetilase/antagonistas & inibidores , Aminopirina N-Desmetilase/metabolismo , Anilina Hidroxilase/antagonistas & inibidores , Anilina Hidroxilase/metabolismo , Animais , Inibidores das Enzimas do Citocromo P-450 , Sistema Enzimático do Citocromo P-450/metabolismo , Citocromos b5/antagonistas & inibidores , Citocromos b5/metabolismo , Lactatos/metabolismo , Ácido Láctico , Glicogênio Hepático/metabolismo , Masculino , Microssomos Hepáticos/metabolismo , Peritonite/etiologia , Peritonite/metabolismo , Piruvatos/metabolismo , Ácido Pirúvico , Ratos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...